These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 5271985

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients.
    Mital OP, Agarwala MC, Singh SK.
    Indian J Chest Dis; 1967 Oct; 9(4):196-206. PubMed ID: 4323543
    [No Abstract] [Full Text] [Related]

  • 23. Late results of treatment of chronic drug-resistant pulmonary tuberculosis.
    Somner AR, Brace AA.
    Br Med J; 1966 Mar 26; 1(5490):775-8. PubMed ID: 5910108
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR.
    Bull Int Union Tuberc; 1968 Dec 26; 41():175-7. PubMed ID: 4885379
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Late results in re-treatment of patients with pulmonary tuberculosis.
    Zierski M, Zachara A.
    Tubercle; 1970 Jun 26; 51(2):172-7. PubMed ID: 5493744
    [No Abstract] [Full Text] [Related]

  • 30. Treatment of resistant pulmonary tuberculosis in Hong Kong with regimens of second-line drugs.
    Horsfall PA.
    Tubercle; 1972 Sep 26; 53(3):166-73. PubMed ID: 4116994
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Improved therapy of tuberculosis with a well tolerated INH derivative (INHG)].
    Sighart H, Opl G.
    Wien Klin Wochenschr; 1969 Nov 04; 81(46):840-1. PubMed ID: 5380791
    [No Abstract] [Full Text] [Related]

  • 33. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
    Pannain M, Tarantino AB, Mac Dowell A, Costa JA, Cunha JM, Pantoja W.
    Rev Bras Med; 1967 Aug 04; 24(8):664-8. PubMed ID: 5603007
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
    Sirota DS, Man'kovetskiĭ EF, Koĭfman SG, Vatsyk MZ.
    Probl Tuberk; 1974 Aug 04; (10):17-9. PubMed ID: 4370967
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Attempt at intermittent chemotherapeutic treatment of patients with bacilli resistant to streptomycin and isoniazid (cooperative survey by the antitubercular services of Marrakech, Meknes, Tangiers)].
    Burzoni FJ, Chicou FJ, Durante C, Hetrick G, Ras R.
    Rev Tuberc Pneumol (Paris); 1969 Nov 04; 33(7):975-86. PubMed ID: 5403000
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis].
    Srednicka-Zajac D, Mysakowska H, Szarewicz-Adamczyk W, Litwin B.
    Ann Univ Mariae Curie Sklodowska Med; 1967 Nov 04; 22():71-8. PubMed ID: 4308440
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.